Safety, Tolerability, and Pharmacodynamic Effect Study of PUR118
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to establish single and multiple dose safety in healthy subjects
and subjects with mild chronic pulmonary obstructive disease (COPD). In addition, the study
will evaluate preliminary proof of concept endpoints in COPD subjects such as biomarkers in
sputum and mucociliary clearance.